PRESS RELEASE published on 05/10/2024 at 22:30, 1 year 6 months ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 Integrated BioPharma, Inc. reports financial results for Q1 2024, showing stable revenue and net income compared to Q1 2023. The company aims to reduce reliance on key customers. Details and future outlook provided Financial Results Revenue Net Income Integrated BioPharma Inc. Customer Base
PRESS RELEASE published on 02/12/2024 at 22:25, 1 year 9 months ago Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 Integrated BioPharma, Inc. reports financial results for the quarters and six-month periods ended December 31, 2023 and 2022, with revenue, operating losses, and net loss figures outlined Financial Results Revenue Integrated BioPharma Inc. Operating Losses Net Loss
PRESS RELEASE published on 11/09/2023 at 20:15, 2 years ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
PRESS RELEASE published on 09/15/2023 at 22:30, 2 years 2 months ago Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
PRESS RELEASE published on 05/11/2023 at 21:30, 2 years 6 months ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023
PRESS RELEASE published on 03/21/2023 at 20:15, 2 years 8 months ago Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
PRESS RELEASE published on 02/10/2023 at 23:00, 2 years 9 months ago Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022
Published on 12/05/2025 at 02:35, 4 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 28 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 13 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
